LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain malignancy known for its fast growth and insensitivity to typical treatments. Research are constantly underway to identify new therapeutic strategies, and recently, a novel biomarker named LCA168 has emerged as a potential avenue for GBM treatment. LCA168 is a protein that is overexpressed in GBM cells compared to